Candel Therapeutics Grants 29,400 Options at $6.18 Under 2025 Plan
Candel Therapeutics granted 29,400 inducement stock options to two newly hired employees at a $6.18 exercise price under its 2025 Inducement Plan. Vesting provisions allocate 25% after one year and the remaining 75% in 36 equal monthly installments, contingent on continued service.
1. Inducement Grants Details
On April 30, Candel Therapeutics’ Compensation Committee granted inducement stock options to two new employees, totaling 29,400 shares of common stock at a per share exercise price of $6.18.
2. Vesting Schedule
The options will vest 25% on the first anniversary of each employee’s start date, with the remaining 75% vesting in 36 equal monthly installments, contingent on continued service at the company.
3. Plan Background
These awards were made under the 2025 Inducement Plan, adopted December 24, 2025, in compliance with Nasdaq Listing Rule 5635(c)(4) as material inducements for the new hires.